This is the authors' abstract. We don't add key points for this paper.
The yeast Candida glabrata is major opportunistic pathogen causing mucosal, and systemic infections in humans. Systemic infections caused by this yeast have high mortality rates, and are difficult to treat due to this yeast’s intrinsic, and frequently adapting antifungal resistance. To understand and treat C. glabrata infections, it is essential to investigate the molecular basis of C. glabrata virulence, and resistance. We established a RNA interference (RNAi) system in C. glabrata by expressing the Dicer and Argonaute genes from Saccharomyces castellii (a budding yeast with natural RNAi). Our experiments with reporter genes, and putative virulence genes showed that the introduction of RNAi resulted in 30-70% gene-knockdown for the construct-types antisense and hairpin, respectively. The resulting C. glabrata RNAi strain was used for the screening of a gene library for new virulence-related genes. Phenotypic profiling with high-resolution quantification of growth identified genes involved in the maintenance of cell integrity, antifungal drugs, and ROS resistance. The genes identified by this approach are promising targets for the treatment of C. glabrata infections.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ishchuk et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: